Pharmaceuticals

Japan Genitourinary Drugs Market Report 2016

  • QYR776913
  • 123 Pages
  • November 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Genitourinary Drugs

Revenue, means the sales value of Genitourinary Drugs

This report studies sales (consumption) of Genitourinary Drugs in Japan market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Astellas

Pfizer

GlaxoSmithKline

Eli Lilly

Bayer AG

Merck

Abbott Laboratories

Bristol-Myers Squibb

Genentech

Roche

Amgen

Botex

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Sex Hormones

Urologicals

Genitourinary Anti-Infectives

Gynaecologicals

Split by applications, this report focuses on sales, market share and growth rate of Genitourinary Drugs in each application, can be divided into

Genitourinary Cancer

Bladder Cancer

Cervical Cancer

Kidney/Renal Cancer

Ovarian Cancer

Prostate Cancer

Table of Contents

Japan Genitourinary Drugs Market Report 2016

1 Genitourinary Drugs Overview

1.1 Product Overview and Scope of Genitourinary Drugs

1.2 Classification of Genitourinary Drugs

1.2.1 Sex Hormones

1.2.2 Urologicals

1.2.3 Genitourinary Anti-Infectives

1.2.4 Gynaecologicals

1.3 Application of Genitourinary Drugs

1.3.1 Genitourinary Cancer

1.3.2 Bladder Cancer

1.3.3 Cervical Cancer

1.3.4 Kidney/Renal Cancer

1.3.5 Ovarian Cancer

1.3.6 Prostate Cancer

1.4 Japan Market Size Sales (Value) and Revenue (Volume) of Genitourinary Drugs (2011-2021)

1.4.1 Japan Genitourinary Drugs Sales and Growth Rate (2011-2021)

1.4.2 Japan Genitourinary Drugs Revenue and Growth Rate (2011-2021)

2 Japan Genitourinary Drugs Competition by Manufacturers

2.1 Japan Genitourinary Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 Japan Genitourinary Drugs Revenue and Share by Manufactures (2015 and 2016)

2.3 Japan Genitourinary Drugs Average Price by Manufactures (2015 and 2016)

2.4 Genitourinary Drugs Market Competitive Situation and Trends

2.4.1 Genitourinary Drugs Market Concentration Rate

2.4.2 Genitourinary Drugs Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 Japan Genitourinary Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 Japan Genitourinary Drugs Sales and Market Share by Type (2011-2016)

3.2 Japan Genitourinary Drugs Revenue and Market Share by Type (2011-2016)

3.3 Japan Genitourinary Drugs Price by Type (2011-2016)

3.4 Japan Genitourinary Drugs Sales Growth Rate by Type (2011-2016)

4 Japan Genitourinary Drugs Sales (Volume) by Application (2011-2016)

4.1 Japan Genitourinary Drugs Sales and Market Share by Application (2011-2016)

4.2 Japan Genitourinary Drugs Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 Japan Genitourinary Drugs Manufacturers Profiles/Analysis

5.1 Astellas

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Genitourinary Drugs Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Pfizer

5.2.2 Genitourinary Drugs Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 GlaxoSmithKline

5.3.2 Genitourinary Drugs Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Eli Lilly

5.4.2 Genitourinary Drugs Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Bayer AG

5.5.2 Genitourinary Drugs Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Merck

5.6.2 Genitourinary Drugs Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Abbott Laboratories

5.7.2 Genitourinary Drugs Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Bristol-Myers Squibb

5.8.2 Genitourinary Drugs Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Genentech

5.9.2 Genitourinary Drugs Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Roche

5.10.2 Genitourinary Drugs Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Roche Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Amgen

5.12 Botex

6 Genitourinary Drugs Manufacturing Cost Analysis

6.1 Genitourinary Drugs Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Genitourinary Drugs

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Genitourinary Drugs Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 Japan Genitourinary Drugs Market Forecast (2016-2021)

10.1 Japan Genitourinary Drugs Sales, Revenue Forecast (2016-2021)

10.2 Japan Genitourinary Drugs Sales Forecast by Type (2016-2021)

10.3 Japan Genitourinary Drugs Sales Forecast by Application (2016-2021)

10.4 Genitourinary Drugs Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Genitourinary Drugs

Table Classification of Genitourinary Drugs

Figure Japan Sales Market Share of Genitourinary Drugs by Type in 2015

Figure Sex Hormones Picture

Figure Urologicals Picture

Figure Genitourinary Anti-Infectives Picture

Figure Gynaecologicals Picture

Table Application of Genitourinary Drugs

Figure Japan Sales Market Share of Genitourinary Drugs by Application in 2015

Figure Genitourinary Cancer Examples

Figure Bladder Cancer Examples

Figure Cervical Cancer Examples

Figure Kidney/Renal Cancer Examples

Figure Ovarian Cancer Examples

Figure Prostate Cancer Examples

Figure Japan Genitourinary Drugs Sales and Growth Rate (2011-2021)

Figure Japan Genitourinary Drugs Revenue and Growth Rate (2011-2021)

Table Japan Genitourinary Drugs Sales of Key Manufacturers (2015 and 2016)

Table Japan Genitourinary Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Genitourinary Drugs Sales Share by Manufacturers

Figure 2016 Genitourinary Drugs Sales Share by Manufacturers

Table Japan Genitourinary Drugs Revenue by Manufacturers (2015 and 2016)

Table Japan Genitourinary Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Japan Genitourinary Drugs Revenue Share by Manufacturers

Table 2016 Japan Genitourinary Drugs Revenue Share by Manufacturers

Table Japan Market Genitourinary Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure Japan Market Genitourinary Drugs Average Price of Key Manufacturers in 2015

Figure Genitourinary Drugs Market Share of Top 3 Manufacturers

Figure Genitourinary Drugs Market Share of Top 5 Manufacturers

Table Japan Genitourinary Drugs Sales by Type (2011-2016)

Table Japan Genitourinary Drugs Sales Share by Type (2011-2016)

Figure Japan Genitourinary Drugs Sales Market Share by Type in 2015

Table Japan Genitourinary Drugs Revenue and Market Share by Type (2011-2016)

Table Japan Genitourinary Drugs Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Genitourinary Drugs by Type (2011-2016)

Table Japan Genitourinary Drugs Price by Type (2011-2016)

Figure Japan Genitourinary Drugs Sales Growth Rate by Type (2011-2016)

Table Japan Genitourinary Drugs Sales by Application (2011-2016)

Table Japan Genitourinary Drugs Sales Market Share by Application (2011-2016)

Figure Japan Genitourinary Drugs Sales Market Share by Application in 2015

Table Japan Genitourinary Drugs Sales Growth Rate by Application (2011-2016)

Figure Japan Genitourinary Drugs Sales Growth Rate by Application (2011-2016)

Table Astellas Basic Information List

Table Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Astellas Genitourinary Drugs Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Genitourinary Drugs Sales Market Share (2011-2016)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline Genitourinary Drugs Sales Market Share (2011-2016)

Table Eli Lilly Basic Information List

Table Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly Genitourinary Drugs Sales Market Share (2011-2016)

Table Bayer AG Basic Information List

Table Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer AG Genitourinary Drugs Sales Market Share (2011-2016)

Table Merck Basic Information List

Table Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Genitourinary Drugs Sales Market Share (2011-2016)

Table Abbott Laboratories Basic Information List

Table Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Abbott Laboratories Genitourinary Drugs Sales Market Share (2011-2016)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol-Myers Squibb Genitourinary Drugs Sales Market Share (2011-2016)

Table Genentech Basic Information List

Table Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genentech Genitourinary Drugs Sales Market Share (2011-2016)

Table Roche Basic Information List

Table Roche Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche Genitourinary Drugs Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Genitourinary Drugs Sales Market Share (2011-2016)

Table Botex Basic Information List

Table Botex Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Botex Genitourinary Drugs Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Genitourinary Drugs

Figure Manufacturing Process Analysis of Genitourinary Drugs

Figure Genitourinary Drugs Industrial Chain Analysis

Table Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015

Table Major Buyers of Genitourinary Drugs

Table Distributors/Traders List

Figure Japan Genitourinary Drugs Production and Growth Rate Forecast (2016-2021)

Figure Japan Genitourinary Drugs Revenue and Growth Rate Forecast (2016-2021)

Table Japan Genitourinary Drugs Production Forecast by Type (2016-2021)

Table Japan Genitourinary Drugs Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370